EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 23.00
-0.35 (-1.50%)
At close: Sep 24, 2026
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 679.18 million as of September 24, 2026. Its market cap has decreased by -65.47% in one year.
Market Cap
679.18M
Enterprise Value
1.08B
Revenue
432.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.00
ChartMarket Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 679.18M, an increase of 768.27%. That is a compound annual growth rate of 18.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 679.18M | -60.21% |
| Dec 30, 2025 | 1.71B | -27.50% |
| Dec 30, 2024 | 2.35B | 142.51% |
| Dec 29, 2023 | 970.72M | 16.78% |
| Dec 30, 2022 | 831.22M | -26.29% |
| Dec 30, 2021 | 1.13B | -2.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.32B |
| Nanexa AB | 1.03B |
| Dicot Pharma AB | 780.46M |
| Cinclus Pharma Holding AB | 547.28M |
| Moberg Pharma AB | 504.83M |
| Orexo AB | 440.01M |
| Enzymatica AB | 411.44M |
| Klaria Pharma Holding AB (publ.) | 145.62M |